NIH PAR · NHLBI · K22
PAR-24-209: NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
To provide highly qualified postdoctoral fellows and other doctoral-level researchers currently in training in the NHLBI Division of Intramural Research with the opportunity to transition their research programs to extramural institutions as junior investigators.
- NOFO number
- PAR-24-209
- Type
- PAR
- Activity code
- K22
- Primary institute
- NHLBI · National Heart, Lung, and Blood Institute
- Clinical trials
- Not Allowed
- Posted
- Jul 15, 2024
- Opens
- Sep 12, 2024
- Expires
- Jul 13, 2027
PAR-24-209 due dates
No application due dates remain in the listed cycles. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| Letter of Intent Due Date(s) |
|---|
| Not Applicable |
| October 12, 2024 |
| November 12, 2024 * |
| Not Applicable |
| March 2025 |
| May 2025 |
| July 2025 |
| February 12, 2025 |
| March 12, 2025 * |
| Not Applicable |
| July 2025 |
| October 2025 |
| December 2025 |
| June 12, 2025 |
| July 12, 2025 * |
| Not Applicable |
| November 2025 |
| January 2026 |
| April 2026 |
| October 12, 2025 |
| November 12, 2025 * |
| Not Applicable |
| March 2026 |
| May 2026 |
What its predecessor PAR-22-034 funded
PAR-24-209 reissues PAR-22-034. Until awards appear under the new number, its funding history is the best guide to who wins under this program: 2 projects and $747K in FY2022–FY2026.
Projects funded
2
Distinct projects, FY2022–FY2026
New awards
2
Type 1 (new project) award records
NIH funding
$747K
Award dollars under PAR-22-034, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 1 | 1 | $249K |
| FY2026 | 2 | 1 | $498K |
Institutions with the most funding
- University of Maryland Baltimore$498K · 1 project
- University of Kentucky$249K · 1 project
Funding institutes
- NHLBI$747K · 3
Activity codes funded
- K223 records
Most recent new awards
- Transgelin Differentially Modulates the Uptake of LDL in Hepatocytes and Smooth Muscle Cells: A New Gene Involved in LDL Clearance and Atherosclerosis. (opens NIH RePORTER)
University of Kentucky · 1K22HL171175-01A1 · NHLBI · Notice Apr 28, 2026
$249KK22
- Use of donor-derived cell-free DNA for risk stratification and post-treatment monitoring of lung transplant patients at risk for chronic lung allograft dysfunction (opens NIH RePORTER)
University of Maryland Baltimore · 1K22HL166368-01 · NHLBI · Notice Jul 4, 2025
$249KK22
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
2 NIH institutes and offices take applications under PAR-24-209. Contact the program officer at the institute that fits your research before applying.
- NHLBI · National Heart, Lung, and Blood Institute
- none
Related notices
Mar 31, 2025
This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.
Apr 4, 2024 · NOT-OD-24-084
Overview of Grant Application and Review Changes for Due Dates on or after January 25, 2025.
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022 · NOT-OD-22-189
Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Award terms
- Application types allowed
- NewResubmission The OER Glossary and the How to Apply - Application Guide provides details on these application types.
- Award budget
- Information
- Project period
- The total period of support is five years up to two years intramural, plus three years extramural). Other
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-22-034.
- Companion NOFOs: PAR-24-211.
Other open NOFOs for K22
- PAR-24-211NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)NHLBI
- PAR-25-251NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)NIAID · next due Feb 12, 2027
- PAR-25-215Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)NINDS · next due Feb 12, 2027
- PAR-25-216Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)NINDS · next due Feb 12, 2027
- PAR-25-027NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)NIDCR · next due Feb 12, 2027
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.